Status:
COMPLETED
Effect of Interleukin 6 Receptor Antagonists in SARS-CoV-2 Patients
Lead Sponsor:
Assiut University
Conditions:
Corona Virus Infection
Eligibility:
All Genders
18-80 years
Brief Summary
1. Investigate the possible effects of interleukin-6 receptor antagonists such as tocilizumab and sarilumab on the levels of IL-6, inflammtory and anti-inflammtory markers and cytokines before and aft...
Detailed Description
An outbreak of a mutated respiratory virus that belongs to the Coronavirus family was reported in mid-December 2019, in Wuhan, China. The virus was named as severe acute respiratory syndrome coronavir...
Eligibility Criteria
Inclusion
- must be critically ill coronavirus disease-19
Exclusion
- patients receiving corticosteroids
- pregnancy
- active TB
- bacterial infection
- fungal infection
- co-infection with other hepatitis viruses.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 24 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05367882
Start Date
February 1 2022
End Date
July 24 2023
Last Update
July 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AssiutU
Asyut, Egypt, 71515